Original price was: $659.00.Current price is: $590.00.



14-Hydroxymorphinone, is likely a schedule II controlled substance similar to other drugs in this class, is an opioid morphine based analgesic agent for pain. It is very similar to oxymorphone with only one carbon-carbon double bond difference on the ring containing the carbonyl group. 14-Hydroxymorphinone is very similar to oxycodone with only one carbon-carbon double bond difference on the ring containing the carbonyl group and an oxymethyl group off the benzene ring. 14-Hydroxymorphinone is a synthetic intermediate to other opioid agents.

Why do you need a 14-Hydroxymorphinone monograph?

Superior Toxicology and Wellness’s monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs)

  • The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
  • A listing of all cited references utilized in the derivation of the OEL and ADE
  • An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA’s Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of Superior Toxicology and Wellness monographs:

  • Full drug documentation. The report consists of 10-12 pages in length, with calculations and cited references.
  • Quick delivery! 24-48 hours of purchase. Sometimes even an instant download.
  • Save money. Similar reports will cost you potentially 5-12 times more.
  • Search our other reports!


There are no reviews yet.

Be the first to review “14-Hydroxymorphinone”

Your email address will not be published. Required fields are marked *